zentalis
Sr Medical Science Liaison - West Region
Sr Medical Science Liaison – West Region Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types. Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investigationa
Sr Medical Science Liaison - Southeast Region
Sr Medical Science Liaison – Southeast Region Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types. Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investiga
Sr Medical Science Liaison – Northeast Region
Sr Medical Science Liaison – Northeast Region Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types. Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investiga
Associate Director Clinical Contracts
ASSOCIATE DIRECTOR CLINICAL CONTRACTS Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types. Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investigational f
Associate Director Clinical Contracts
Sr Medical Science Liaison - Central Region
Sr Medical Science Liaison – Central Region Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types. Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investigati
Sr Medical Science Liaison - Central Region
Associate Director Medical Writing
ASSOCIATE DIRECTOR, MEDICAL WRITING Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types. Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investigational fir